Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Express Scripts to Drop Big Sellers From AbbVie, Gilead in 2019
Bloomberg
Tue, 08/7/18 - 11:24 am
Tags:
Express Scripts, PBMs, Gilead Sciences, HIV, Atripla, AbbVie, Mavyret, hepatitis C
AbbVie surprised investors with its hepatitis C success. Will it last?
Biopharma Dive
Sat, 08/4/18 - 11:43 am
Tags:
AbbVie, hepatitis C, Mavyret
Would AbbVie’s top execs really pull the trigger on a $30B M&A deal? Why, yes, actually
Endpoints
Mon, 07/30/18 - 11:46 am
Tags:
AbbVie, M&A
2 Reasons the Market Frowned After AbbVie's Blowout Q2 -- and 1 Reason It Should Be Excited
Motley Fool
Fri, 07/27/18 - 07:13 pm
Tags:
AbbVie, earnings, Humira, Mavyret
As Humira competition nears, AbbVie's Imbruvica and Mavyret pick up steam
Fierce Pharma
Fri, 07/27/18 - 07:05 pm
Tags:
AbbVie, Humira, Imbruvica, Mavyret
AbbVie tops second-quarter estimates, sets higher earnings target
Reuters
Fri, 07/27/18 - 12:30 pm
Tags:
AbbVie, earnings
pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in
RAPS.org
Thu, 07/26/18 - 07:28 pm
Tags:
Novartis, Merck, GSK, Gilead Sciences, Bayer, AstraZeneca, AbbVie, Takeda, FDA, DDIs, drug-drug interactions, proton pump inhibitors
AbbVie's new endometriosis drug to cost $10K per year
Biopharma Dive
Tue, 07/24/18 - 11:27 pm
Tags:
FDA, AbbVie, endometriosis, Orilissa, drug pricing
AbbVie wins FDA approval for oral treatment for endometriosis pain
Marketwatch
Tue, 07/24/18 - 10:21 am
Tags:
AbbVie, endometriosis, Orilissa
7 companies to watch during Q2 earnings
Biopharma Dive
Sun, 07/22/18 - 12:41 pm
Tags:
earnings, Biogen, Gilead Sciences, Amgen, Celgene, AbbVie, Pfizer, Spark Therapeutics
Mylan signs U.S. license deal on Humira with AbbVie
Yahoo/Reuters
Tue, 07/17/18 - 09:48 am
Tags:
AbbVie, Mylan, biosimilars, Humira
Keep Your Eyes on Healthcare's Odd Couple: AbbVie and Alphabet
Motley Fool
Thu, 07/12/18 - 09:29 am
Tags:
AbbVie, Calico, Alphabet, age-related disease, cancer, drug development
AbbVie's stock falls after lymphoma treatment trial data disappoints
Marketwatch
Wed, 07/11/18 - 10:19 am
Tags:
AbbVie, ibrutinib, clinical trials, lymphoma
AbbVie wins reversal of $140 million verdict in case over AndroGel risks
Reuters
Fri, 07/6/18 - 11:15 am
Tags:
AbbVie, Androgel, testosterone
Pharma's 2 Biggest Setbacks in 2018
Motley Fool
Sun, 07/1/18 - 11:29 am
Tags:
AbbVie, Celgene, Rova-T, ozanimod
AbbVie, AndroGel partner owe $448 million in antitrust case - U.S. judge
Yahoo/Reuters
Fri, 06/29/18 - 09:26 pm
Tags:
AbbVie, Androgel, generics, antitrust
Galapagos shares are tumbling following disappointing results from a cystic fibrosis trial.
Motley Fool
Fri, 06/29/18 - 11:17 am
Tags:
Galapagos, AbbVie, cystic fibrosis, Vertex Pharmaceuticals, GLPG2737
Argenx Receives Milestone Payment from AbbVie for Preclinical Oncology Drug
CP Wire
Thu, 06/28/18 - 10:10 am
Tags:
Argenx, AbbVie, ARGX-115, cancer
3 Biotech Stocks With Major Potential Catalysts in July
Yahoo/Motley Fool
Wed, 06/27/18 - 09:45 am
Tags:
Neurocrine Biosciences, AbbVie, Progenics, INSYS Therapeutics, Elagolix, endometriosis, Azedra, adrenal tumors, Syndros
AbbVie shares rise on $1 bln investment in partnership with Alphabet-backed health company
Marketwatch
Tue, 06/26/18 - 10:09 am
Tags:
AbbVie, Calico Life Sciences, Alphabet, drug development

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.